









Markets
/
Stocks
/
nasdaq-esta
/

Establishment Labs Holdings Inc

ESTA



View Detailed Chart

76.450USD

+0.800+1.06%

Close 12/26, 16:00（ET）Quotes delayed by 15 min

2.22BMarket Cap

LossP/E TTM



Establishment Labs Holdings Inc

76.450

+0.800+1.06%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Intraday

30m

Today

+1.06%

5 Days

+2.73%

1 Month

+12.41%

6 Months

+87.19%

Year to Date

+65.94%

1 Year

+65.33%

View Detailed Chart

TradingKey Stock Score of Establishment Labs Holdings Inc

Currency: USD Updated: 2025-12-26

Key Insights

Establishment Labs Holdings Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 16/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 74.22.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Establishment Labs Holdings Inc's Score

Industry at a Glance

Industry Ranking

16 / 207

Overall Ranking

83 / 4563

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Analyst Rating

Based on 9 analysts

Buy

Current Rating

74.222

Target Price

+4.27%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Establishment Labs Holdings Inc Highlights

StrengthsRisks

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.

Undervalued

The company’s latest PE is -26.84, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 30.64M shares, decreasing 0.02% quarter-over-quarter.

Held by Ron Baron

Star Investor Ron Baron holds 1.18M shares of this stock.